Nanosphere Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 142
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $102M
Latest Deal Amount

Nanosphere General Information

Description

molecular diagnostic tests. The company engages in research and development of diagnostic test platform that helps in disease detection, optimal patient treatment and improved healthcare economics.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Decision/Risk Analysis
Other Industries
Social/Platform Software
Acquirer
Primary Office
  • 4088 Commercial Avenue
  • Northbrook, IL 60062
  • United States
+1 (847) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanosphere Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 30-Jun-2016 $102M 00000 00000 Completed Generating Revenue
9. PIPE 11-May-2015 00.00 00000 Completed Generating Revenue
8. Debt - General 07-May-2015 0000 00000 Completed Generating Revenue
7. PIPE 19-Jul-2012 0000 00000 Completed Generating Revenue
6. IPO 01-Nov-2007 0000 00000 00000 Completed Generating Revenue
5. Later Stage VC (Series D) 26-Apr-2006 0000 00000 00000 Completed Generating Revenue
4. Later Stage VC (Series C2) 14-Oct-2004 0000 000.00 000.00 Completed Startup
3. Later Stage VC (Series C) 26-Nov-2002 0000 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) $9M $12.4M 000.00 Completed Startup
1. Early Stage VC (Series A) 14-Jan-2000 $3.42M $3.42M 000.00 Completed Product Development
To view Nanosphere’s complete valuation and funding history, request access »

Nanosphere Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 000,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C2 000,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C 10,066,673 $0.010000 8% $0.6 $0.6 1x $0.6 2.24%
Series B 17,007 $0.010000 8% $2.21 $2.21
To view Nanosphere’s complete cap table history, request access »

Nanosphere Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
molecular diagnostic tests. The company engages in research and development of diagnostic test platform that helps in di
Decision/Risk Analysis
Northbrook, IL
142 As of 2016
00000
0000 0000-00-00
000000&0 00000

0000000

ulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mo
0000000000000 00000000
Vancouver, Canada
00.00
0000000 0000 00.00

00000000

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud e
00000 0000000000 00000000
Westminster, CO
00.00
0000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanosphere Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Canexia Health Private Equity-Backed Vancouver, Canada 00.00 0000000 0000 00.00
00000000 000000000 Angel-Backed Westminster, CO 00.00 0000000000 00.00
00000000 0000 Formerly VC-backed Warren, NJ 00 00000 000000&0 00000
000000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 0000000000 0 000.00
To view Nanosphere’s complete competitors history, request access »

Nanosphere Executive Team (13)

Name Title Board Seat Contact Info
Kenneth Bahk Ph.D Chief Strategy Officer
Farzana Moinuddin Chief Accounting Officer
Zachary Crowther Director, Marketing
Jim Hully Ph.D Director, Product Development
Teresa Raich Ph.D Senior Director, Clinical and Regulatory Affairs
You’re viewing 5 of 13 executive team members. Get the full list »

Nanosphere Board Members (8)

Name Representing Role Since
Gene Cartwright Self Board Member 000 0000
Jeff Randall Self Board Member 000 0000
R. Holmlin Ph.D Self Director 000 0000
Sheli Rosenberg JD Nanosphere Chairman 000 0000
You’re viewing 4 of 8 board members. Get the full list »

Nanosphere Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanosphere Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Allen & Company Investment Bank Minority 000 0000 000000 0
Bain Capital Ventures Venture Capital Minority 000 0000 000000 0
Lurie Investment Fund Corporate Venture Capital Minority 000 0000 000000 0
NGEN Partners Venture Capital Minority 000 0000 000000 0
Oxford Finance Lender/Debt Provider 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »